Join us tomorrow at 3:30PM EST for our #ECMO journal club on @zoom_us with @CANCARESociety and @barryburstein. See details to log in on flyer or DM me. #ICU #CVICU #Cardiotwitter #JACC #ACC #CTSurgery #ACCFIT #FOAMed https://t.co/vWWryEI13F

Privilege to be invited by @hvanspall to contribute to her review of interventions to improve clinical outcomes following HF hospitalization https://t.co/mLaPpnFEhZ @hvanspall has published great work in this space. @DrMarthaGulati @ShelleyZieroth @gina_lundberg @AnastasiaSMihai

Key opportunity to improve care and pt-centered outcomes for HF, that has not been a primary focus for clinician education, quality metrics, or QI initiatives: Optimal dosing of GDMT. Let’s get to it. @rcstarling @coconnormd @JavedButler1 @JJheart_doc @MinnowWalsh @NMHheartdoc https://t.co/GvaOd8eksm

Excellent news... 1st National HF Awareness Week in Canada! May 6-12 2019! Looking frwrd to being involved. ??? Great job @HeartLifeCanada @CanHFSociety @HeartandStroke https://t.co/chd6hCJy3u

We are pleased to announce the official launch of our brand new website https://t.co/ORndXNCm4E . Check it out today! @ShelleyZieroth @JustinEzekowitz @DktrV @lizswiggum @AniqueDucharme @SCC_CCS @SCC_CCS_Trainee @CANCARESociety @CHRS_SCR @CSEchoCa https://t.co/Jb1EJuZMZH

We are pleased to announce the official launch of our brand new website https://t.co/ORndXNCm4E. Check it out today! @ShelleyZieroth @JustinEzekowitz @DktrV @lizswiggum @AniqueDucharme @SCC_CCS @SCC_CCS_Trainee @CANCARESociety @CHRS_SCR @CSEchoCa https://t.co/TrQKPDlvW1

If you've enjoyed our #guideline related videos, you'll enjoy our #CCS e-Guidelines website where you'll find comprehensive versions of our major guidelines! @ShelleyZieroth @AniqueDucharme https://t.co/J5fyoet26o

For heart failure with reduced EF ‘Over ~2–4 years higher versus lower doses of ACEIs, ARBs or BBs did not significantly reduce all-cause mortality or all cause hospitalizations’ very nice work @medmyths et al https://t.co/rV7F4hqgue #TooMuchMedicine #ChoosingWisely #NHS https://t.co/3EDtHMXSoZ

Titrate to target doses in #HeartFailure? Higher doses of ACEI/ARBs reduce risk of HF worsening vs lower doses, and higher doses of ARBs reduce risk of HF hospitalization, but also increase adverse effects: https://t.co/zvrwSjPoQh @Ricky_Turgeon @medmyths

Great podcast @JustinEzekowitz !! @SCC_CCS @SCC_CCS_Trainee @CHRS_SCR @CANCARESociety https://t.co/UhJv4ZMDtr